Axa S.A. Has $8.59 Million Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Axa S.A. lowered its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 52.1% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 26,731 shares of the company’s stock after selling 29,112 shares during the period. Axa S.A.’s holdings in HCA Healthcare were worth $8,588,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Steward Partners Investment Advisory LLC grew its stake in HCA Healthcare by 49.0% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 1,993 shares of the company’s stock valued at $539,000 after acquiring an additional 655 shares during the period. Stifel Financial Corp increased its stake in HCA Healthcare by 19.8% during the 4th quarter. Stifel Financial Corp now owns 63,429 shares of the company’s stock worth $17,180,000 after purchasing an additional 10,491 shares in the last quarter. TFO Wealth Partners LLC boosted its holdings in shares of HCA Healthcare by 61,450.0% in the fourth quarter. TFO Wealth Partners LLC now owns 1,231 shares of the company’s stock valued at $333,000 after buying an additional 1,229 shares during the period. Dorsey & Whitney Trust CO LLC raised its holdings in shares of HCA Healthcare by 21.0% during the fourth quarter. Dorsey & Whitney Trust CO LLC now owns 1,501 shares of the company’s stock worth $406,000 after acquiring an additional 260 shares during the period. Finally, Bank of Nova Scotia boosted its stake in HCA Healthcare by 56.6% in the 4th quarter. Bank of Nova Scotia now owns 112,796 shares of the company’s stock worth $30,531,000 after purchasing an additional 40,790 shares during the period. 62.73% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on HCA. Wells Fargo & Company upped their price objective on HCA Healthcare from $315.00 to $365.00 and gave the stock an “equal weight” rating in a research report on Tuesday, July 30th. Truist Financial lifted their price objective on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a report on Monday, August 19th. Wolfe Research raised shares of HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. Leerink Partners increased their price objective on shares of HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 24th. Finally, Deutsche Bank Aktiengesellschaft increased their price target on HCA Healthcare from $359.00 to $375.00 and gave the company a “buy” rating in a research report on Friday, June 28th. Five analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and three have assigned a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $359.89.

HCA Healthcare Price Performance

HCA Healthcare stock opened at $403.28 on Friday. The stock’s 50 day moving average is $378.91 and its 200-day moving average is $343.05. The company has a market capitalization of $105.62 billion, a price-to-earnings ratio of 20.10, a PEG ratio of 1.52 and a beta of 1.67. HCA Healthcare, Inc. has a 12 month low of $215.96 and a 12 month high of $409.42. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.97 by $0.53. The company had revenue of $17.49 billion during the quarter, compared to analysts’ expectations of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. HCA Healthcare’s quarterly revenue was up 10.3% on a year-over-year basis. During the same quarter in the previous year, the business posted $4.29 earnings per share. Equities research analysts expect that HCA Healthcare, Inc. will post 22.46 EPS for the current year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be issued a $0.66 dividend. The ex-dividend date of this dividend is Monday, September 16th. This represents a $2.64 annualized dividend and a yield of 0.65%. HCA Healthcare’s dividend payout ratio is presently 13.16%.

Insider Buying and Selling

In other news, SVP Kathryn A. Torres sold 1,857 shares of the business’s stock in a transaction that occurred on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total value of $659,327.85. Following the completion of the transaction, the senior vice president now directly owns 17,755 shares in the company, valued at approximately $6,303,912.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total transaction of $659,327.85. Following the completion of the sale, the senior vice president now directly owns 17,755 shares in the company, valued at $6,303,912.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the transaction, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 17,202 shares of company stock worth $6,407,273. Company insiders own 1.60% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.